Incyte Corp (NASDAQ:INCY)

Add to Watch List

Set Alert

22.11 Real-Time Quote	-0.21 / -0.94% Today’s Change	15.43 Today\|\|\|52-Week Range 26.30	+33.11% Year-to-Date

22.11

Real-Time Quote

-0.21 / -0.94%

Today’s Change

15.43

Today|||52-Week Range

26.30

+33.11%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$3.0B

Company Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Contact Information

Incyte Corp.

Experimental Station

Wilmington Delaware 19880

P:(302) 498-6700

Investor Relations:
(302) 498-6944

www.incyte.com

Employees

Shareholders

Mutual fund holders	72.74%
Other institutional	41.42%
Individual stakeholders	15.54%

Top Executives

David C. Hastings, CPA	Chief Financial Officer & Executive Vice President
Richard S. Levy, MD	EVP, Chief Drug Development & Medical Officer
James M. Daly, MBA	Chief Commercial Officer & Executive VP
Eric H. Siegel, MBA	Secretary, Executive VP & General Counsel
Laurent Chardonnet, MBA	Treasurer & Vice President

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.